Variability of IOP following laser photocoagulation used in the treatment of diabetic retinopathy
DOI:
https://doi.org/10.18203/2349-2902.isj20174511Keywords:
DR, IOPAbstract
Background: Diabetic retinopathy (DR) is the leading cause of blindness in most industrialized countries. This study was undertaken to assess the variability of IOP following laser photocoagulation used in the treatment of diabetic retinopathy.
Methods: This study was conducted at Department of Opthalmology, B.R.D. Medical College, Gorakhpur from June 2015 to December 2016. This study was intended to see the onset and duration of intraocular pressure spikes in diabetic retinopathy patients after green laser photocoagulation (532 nm) (Nidek). Forty patients were followed for next 3 months. The data was analysed by using SPSS version 15.0. Chi-square test and T test was used.
Results: Out of 40 patients, 2 (5%) had background Diabetic retinopathy (DR) with maculopathy, 10 (25%) having pre-proliferative DR, 28 (70%) having proliferative DR. Out of 2 BDR patients, 1 (50%) developed immediate post laser angle closure (Schaffer's grade 1) which persisted for 3 days and another had shown no change in angle structure. Out of 10 PPDR patients, no one developed post laser angle closure (0%). Out of 28 PDR patients, 6 (21.4%) had post laser angle closure which included 4 patients who had angle closure before laser, that means around 7% patients developed angle closure in this group. Among these 2 patients, 1 developed angle closure immediately (Schaffer's grade 1) and another developed the same 1 day later and this angle closure (Schaffer's grade 1) remained for 3 days.
Conclusions: Laser photocoagulation in diabetic retinopathy patients can cause increase in IOP.
References
Yanoff M, Jays Duker. Ophthalmology third edition.Mosby Elsevier Publications; 2013;4:613.
Klein R, Klein B, Moss SE. Epidemiology of proliferative diabetic retinopathy. Diabetes Care. 1992;15(12):1875-91.
Klein R, Klein BE, Moss SE, Cruickshanks KJ. The Wisconsin epidemiologic study of diabetic retinopathy XIV. Ten-year incidence and progression of diabetic retinopathy. Arch Ophthalmol. 1994;112:1217-28.
Diabetic retinopathy study research group. Four risk factors for severe visual loss in diabetic retinopathy. the third report from the Diabetic Retinopathy Study. Arch Ophthalmol. 1979;97(4):654-5.
Ferris FL 3rd, Podgor MJ, Davis MD. Macular edema in diabetic retinopathy study patients. diabetic retinopathy study report number 12. Ophthalmol. 1987;94(7):754-60.
Shimura M, Yasuda K, Nakazawa T, Tamai M. Visual dysfunction after panretinal photocoagulation in patients with severe diabetic retinopathy and good vision. Am J Ophthalmol. 2005;140(1):8-15.
Mensher JH. Anteroir chamber depth alteration after retinal photocoagulation. Arch Ophthalmol. 1977;95:113-6.
Hsiao Ch, Hsu CT, Shen SC, Chen HS. Mid-term follow up of Nd:YAG laser iridectomy in Asian eyes. Am J Ophthalmol. 2001;131:7-12.
Wetzel W. Ocular aqueous humour dynamics after photodisruptive laser surgery procedures. Ophthalmic Surg. 1994;25:298-302.
Schubert HD. Vitreoretinal changes associated with rise in intraocular pressure after Nd:YAG capsulotomy. Ophthalmic Surg. 1987;18:19-22.
Stewart DE. Parson's diseases of eye 12th edition. Churchill Livingstone; 1959:274.
Nentwich MM, Ulbig MU. Diabetic retinopathy - ocular complications of diabetes mellitus. World J Diabetes. 2015;6(3):489-99.
Chowdhuury TA, Hopkins D, Dodson PM, Vafidis GC. The role of serum lipids in exudative diabetic maculopathy: is there a place for lipid lowering therapy?. Eye (Lond). 2002;16(6):689-93.
Blondeau P, Pavan PR, Phelps CD. Acute pressure elevation following panretinal photocoagulation. Arch Ophthalmol. 1981;99:1239.
